Skip to main content
. 2020 Jul;18(7):655–672. doi: 10.2174/1570159X17666191127112339

Table 2.

Ligands of the group II mGlu cited in the text.

Ligands Pharmacological Profile Refs.
(2R,4R)-APDC Broad spectrum group II mGlu agonist, also active at other mGlu receptors [1, 103]
DGC-IV Broad spectrum group II mGlu agonist [1, 104]
NAAG mGlu3 agonist [123, 124]
LY354740 mGlu2/3 agonist [13, 106, 107]
LY379268 mGlu2/3 agonist [13, 106, 107]
LY341495 Broad spectrum group II mGlu antagonist [110]
LY541850 Mixed ligand (mGlu2 agonist / mGlu3 antagonist) [1]
LY566332 mGlu2 PAM [99, 113]
LY2389575 mGlu3 NAM [114]
BINA mGlu2 PAM [112]
ML 337 mGlu3 NAM [116]
DN10 Nanobody, mGlu2 PAM, partial agonist at mGlu2 [17]
DN13 Nanobody, mGlu2 PAM [17]